ESR1 and cancer: Despite the fact that triple-negative breast cancer is characterized by a lack of ERα expression [136], data suggest that estrogen still plays a critical role in the etiology of this type of cancer since a 36-kDa variant of ERα, known as ER alpha 36 (ERα36), is highly expressed in triple-negative breast cancer [137] and is involved in rapid estrogen signaling [138].